Est. 2001·3,000+ placements · six offices · four regions

MitchelLake Intelligence

Oceania

Live market signals and executive-talent analysis across Australia, New Zealand and the Pacific.

Cegid · capital raising

Five days, $17.9 billion: the capital deployments behind next quarter's leadership demand

Cegid's €1.1B private-credit loan, KKR's $1B first close, Blackstone's $13.1B Asia fund and Ciena's $2.5B convertible — four deployments in five days, and capital-raising signals now at 17.6% of market flow.

Latest signals — Oceania

Early stage

≤ series b · ≤ us$30m

US$0.0M

early-stage quantum · trailing 28 days · Oceania

0

qualifying raises

Series B and below, round size ≤ US$30M, verified sources only. The ledger accumulates weekly.

No verified early-stage raises in the current window for Oceania — the freshest venture flow is on the global wire.

Analysis

On the wire — Oceania

Our intelligence attributed 2,211 signals to Oceania in the trailing four weeks. Below is the verified, sourced selection — every entry carries a checked source link and persists as its own page.

Nine Entertainment Co
Xero
MYOB
Canva
THG
Toast
Digital Turbine
Emesent
David Jones
Nine
Elastic

Last updated

How this connects

Related companies

Recent developments

Proof — case studies

In their words

Many private companies are conducting private fundraising not because they need the capital, but because they require liquidity to retain their talent.
Emma Norchet, Partner in T. Rowe Price's private opportunities fund investment committee and member of the centralised private equity team for the US equity division, T. Rowe Price Group · context
International expansion is one of our four key strategic growth pillars.
Vikesh Ramsunder, CEO, Sigma Healthcare · context
International growth is one of Sigma's four key strategic growth pillars and the Company remains committed to driving growth in its core offshore markets, while assessing and seeding new markets. This includes the UK where Sigma recently announced a Memorandum of Understanding (MoU) with Greenlight Healthcare. Sigma engaged in the Boots sale process given the potentially unique opportunity it presented to accelerate its UK expansion through the market-leading Boots brand and large footprint. However, following its preliminary review the Company has concluded that such an acquisition would not currently meet its strategic and capital investment objectives.
Sigma Healthcare Ltd, Sigma Healthcare Ltd · context